TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Legemiddelansvarsforeningen
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
1,338
|
2,221
|
2,101 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
822
|
1,505
|
1,497 |
| Total assets |
21,318
|
21,861
|
21,475 |
| Current assets |
9,807
|
21,861
|
21,475 |
| Current liabilities |
186
|
143
|
141 |
| Equity capital |
21,131
|
21,718
|
21,334 |
| - share capital |
0
|
0
|
0 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
99.1%
|
99.3%
|
99.3% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
61.4%
|
67.8%
|
71.3% |
| Return on assets (ROA) |
3.9%
|
6.9%
|
7.0% |
| Current ratio |
5272.6%
|
15287.4%
|
15230.5% |
| Return on equity (ROE) |
3.9%
|
6.9%
|
7.0% |
| Change turnover |
-742
|
231
|
119 |
| Change turnover % |
-36%
|
12%
|
6% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.